Skip to main content
. Author manuscript; available in PMC: 2020 Jan 24.
Published in final edited form as: Pharmacogenomics J. 2019 Feb 4;19(6):528–537. doi: 10.1038/s41397-019-0076-2

Table 2.

Patient-Reported Discussions Surrounding Medication Changes: Case vs. Control

Survey Question Case Control Odds Ratio (95% CI, p-value)
Did your healthcare provider stop or change one of your medications today or start a new medication? 280 (69.7) 66 (71.0) 1.0 (0.6–1.8, p=0.97)
Did your healthcare provider discuss specific factors about you or your personal make-up which would suggest that you were more likely or less likely than other patients to benefit from the medication change or new medication? 147 (61.5) 36 (66.7) 0.7 (0.3–1.8, p=0.51)
Did your healthcare provider discuss your genetics or your DNA when talking about the medication change or new medication? 67 (28.2) 5 (9.3) 5.6 (1.7–18.2, p=0.004)
Did your healthcare provider discuss a specific genetic test result for you when talking about the medication change or new medication? 57 (24.1) 0 (0.0) p<0.051
Did your healthcare provider say that a specific genetic test result for you helped him or her make a better prescribing decision regarding your medication change or new medication? 60 (25.5) 0 (0.0) p<0.051

Values are represented as number of patients who responded “yes” (%)

CI = confidence interval

1

Statistical modeling was non-estimable due to zero “yes” responses from those in the control group.